{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:42:24Z","timestamp":1786470144956,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory disease of apocrine gland\u2013bearing areas characterized by abscesses, tunneling, scarring, and recurrent flares. Surgical excision is central in refractory disease, but perioperative protocols are variable. We evaluated whether specific perioperative medical therapies are associated with shorter time to documented postoperative wound-healing progress after HS surgery, and whether intraoperative cultures meaningfully guide antibiotic management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 194 HS surgeries performed at a quaternary care center between January 1, 2013, and July 1, 2021. We abstracted perioperative medical therapies (including antibiotics and spironolactone), intraoperative culture results, postoperative antibiotics, and healing times from the medical record. Healing was defined as days from surgery to the first follow-up note documenting substantial wound-healing progress. Time to healing was analyzed with Kaplan-Meier survival curves and Cox proportional hazards models. We also examined whether intraoperative cultures were associated with postoperative antibiotic selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Perioperative trimethoprim-sulfamethoxazole was associated with shorter time to documented healing [hazard ratio (HR) 2.55, 95% CI: 1.46\u20134.46,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.00099]. Preoperative cephalexin was also associated with shorter time to heal (HR: 4.17, 95% CI: 1.40\u201312.44,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.01), whereas postoperative cephalexin was not (HR: 0.89, 95% CI: 0.44\u20131.79,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.74). Perioperative spironolactone was associated with faster healing (HR: 5.72, 95% CI: 2.08\u201315.74,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.00073). Intraoperative cultures were collected in 28% of surgeries, yielded gram-positive, gram-negative, and anaerobic organisms, showed only weak, nonsignificant associations with preoperative antibiotic exposure, and were not significantly associated with postoperative antibiotic choice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Perioperative trimethoprim-sulfamethoxazole, cephalexin, and spironolactone were each associated with shorter time to documented wound-healing progress after HS surgery in this retrospective cohort. Routine intraoperative cultures demonstrated limited observed clinical utility in guiding immediate postsurgical antibiotics. These findings support efforts to streamline perioperative care while de-emphasizing routine intraoperative culture collection in HS surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sap.0000000000004777","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:00:18Z","timestamp":1779894018000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Shorter Wound-healing Times Associated With Select Perioperative Medical Therapies in Hidradenitis Suppurativa Surgery, and a Limited Clinical Role of Intraoperative Cultures"],"prefix":"10.1097","volume":"97","author":[{"given":"Shaan","family":"Sekhon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Tompkins-Rhoades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miracle","family":"Uzoekwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Rajaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydni","family":"Sheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-0901","authenticated-orcid":false,"given":"Scott L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaad.2009.03.043","article-title":"Hidradenitis suppurativa and associated factors: still unsolved problems","volume":"61","author":"Matusiak","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis","volume":"157","author":"Jfri","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"key":"R5-20260811","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clindermatol.2016.10.018","article-title":"Treatments for hidradenitis suppurativa","volume":"35","author":"Andersen","year":"2017","journal-title":"Clin Dermatol"},{"key":"R6-20260811","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study","volume":"65","author":"Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R11-20260811","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","article-title":"Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?","volume":"13","author":"Alhusayen","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","article-title":"A systematic review of treatments for hidradenitis suppurativa","volume":"148","author":"Rambhatla","year":"2012","journal-title":"Arch Dermatol"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/antibiotics12060978","article-title":"Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues","volume":"12","author":"Molinelli","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring","year":"2017","journal-title":"Br J Dermatol"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jaad.2015.07.044","article-title":"Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis","volume":"73","author":"Mehdizadeh","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R16-20260811","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DSS.0000000000002892","article-title":"Current surgical management of Hidradenitis suppurativa: a systematic review and meta-analysis","volume":"47","author":"Riddle","year":"2021","journal-title":"Dermatol Surg"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2023.04.025","article-title":"Trimethoprim\/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: a series of 16 cases","volume":"37","author":"Masson","year":"2023","journal-title":"JAAD Case Rep"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/JW9.0000000000000135","article-title":"Spironolactone in hidradenitis suppurativa: a single-center","volume":"10","author":"Masson","year":"2024","journal-title":"Int J Womens Dermatol"},{"key":"R19-20260811","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/JW9.0000000000000159","article-title":"Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis","volume":"10","author":"Gangidi","year":"2024","journal-title":"Int J Womens Dermatol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SAP.0000000000004777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:03:35Z","timestamp":1786467815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/SAP.0000000000004777"}},"subtitle":["A 194-Case Retrospective Review"],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004777","relation":{},"ISSN":["0148-7043","1536-3708"],"issn-type":[{"value":"0148-7043","type":"print"},{"value":"1536-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2025-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}